BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2016
View Archived Issues
Bavarian Nordic collaborates with Evaxion Biotech and DTU to develop a novel MRSA vaccine
Read More
GlaxoSmithKline reviews milestones of fourth quarter 2015
Read More
Cue collaborates with Janssen on quantitative HIV viral load test
Read More
Riboxx Pharmaceuticals and Tollys enter agreement for new drug development program
Read More
Vertical Pharmaceuticals, Trigen and Osmotica form combined company
Read More
Cancer Research UK begins phase I study of taladegib
Read More
Zepatier approved in Canada for the treatment of chronic HCV genotypes 1, 3 or 4
Read More
Avita Medical completes sale of its respiratory business
Read More
Amarantus requests FDA rare pediatric disease designation for MANF
Read More
Ember Therapeutics completes reverse merger with American Home Alliance
Read More
FDA issues complete response letter to Vertex for Kalydeco sNDA
Read More
Pfizer discloses phosphodiesterase 4B inhibitors
Read More
ViiV Healthcare patents compounds to treat HIV infection
Read More
Aurigene Discovery Technologies reports Nampt inhibitors
Read More
Bayer Schering Pharma presents antimitotic drugs
Read More
Takeda reviews highlights of third quarter of fiscal 2015
Read More
FDA awards breakthrough therapy designation to IMMU-132 for triple-negative breast cancer
Read More
Recombinant factor VIII exhibits promising profile for the treatment of hemophilia A
Read More
Long-acting FVIIa shows promise for the treatment of hemophilia
Read More
Microbix Biosystems to develop products to combat Zika virus
Read More
Muscular Dystrophy Association to collaborate in MoveDMD trial
Read More
Atlas Genetics' Chlamydia diagnostic receives E.U. approval
Read More
FDA places partial clinical hold on pacritinib
Read More
EBV-CTL granted U.S. orphan status for EBV-positive post-transplant lymphoproliferative disorders
Read More
EMA confirms positive risk-benefit ratio of Xarelto for prevention of stroke in patients with AF
Read More